Hologic announced the election of Wayde McMillan to its Board of Directors, effective April 4, 2025. McMillan was also appointed to the Audit and Finance Committee, bringing significant financial expertise to the board.
McMillan's extensive background includes serving as Chief Financial Officer of Solventum Corporation and 3M Company's Health Care Business Group, as well as Executive Vice President, Chief Financial Officer, and Treasurer of Insulet Corporation.
His deep understanding of the medical technology industry and financial acumen are expected to be valuable assets to Hologic's governance and strategic planning, supporting the company's long-term objectives.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.